Endo International PLC Executives
Endo International employs about 3.1 K people. The company is managed by 28 executives with a total tenure of roughly 207 years, averaging almost 7.0 years of service per executive, having 110.82 employees per reported executive. Discussion of Endo International's management performance can provide insight into the enterprise performance.
| Donald DeGolyer CEO Special Advisor to the CEO |
| Paul Campanelli CEO President CEO, Director |
Endo |
Endo International Management Team Effectiveness
The company has return on total asset (ROA) of 5.11 % which means that it generated a profit of $5.11 on every $100 spent on assets. This is normal as compared to the sector avarege. Endo International's management efficiency ratios could be used to measure how well Endo International manages its routine affairs as well as how well it operates its assets and liabilities.Endo International Workforce Comparison
Endo International PLC is one of the top stocks in number of employees category among related companies. The total workforce of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 46,093. Endo International holds roughly 3,103 in number of employees claiming about 7% of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of (24.82) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 24.7 %, which suggests for every 100 dollars of sales, it generated a net operating income of $24.7. Endo International Notable Stakeholders
An Endo International stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Endo International often face trade-offs trying to please all of them. Endo International's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Endo International's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Donald DeGolyer | Special Advisor to the CEO | Profile | |
| Paul Campanelli | President CEO, Director | Profile | |
| Rajiv Silva | CEO and President and Director | Profile | |
| Roger Kimmel | Chairman of the Board | Profile | |
| Carrie Nichol | Chief Accounting Officer, Vice President Controller | Profile | |
| Brian Lortie | President U.S. Branded Pharmaceuticals | Profile | |
| Antonio Pera | President - Par Pharmaceutical | Profile | |
| Domenic Ciarico | Executive Vice President Chief Commercial Officer - Sterile and Generics | Profile | |
| Patrick Barry | Executive Vice President and Chief Commercial Officer | Profile | |
| Daniel Rudio | Senior Vice President Chief Accounting Officer, Controller | Profile | |
| Camille Farhat | President of American Medical Systems, Inc | Profile | |
| Blaise Coleman | Senior Vice President of Global Finance Operations and Interim CFO | Profile | |
| Terrance Coughlin | COO, Executive Vice President | Profile | |
| Matthew Maletta | Executive Vice President Chief Legal Officer | Profile | |
| Suketu Upadhyay | CFO and Executive VP | Profile | |
| Susan Hall | Chief Scientific Officer, Global Head of RandD and Quality and Executive VP | Profile | |
| William Spengler | Director | Profile | |
| Arthur Higgins | Independent Director | Profile | |
| William Montague | Director | Profile | |
| Michael Hyatt | Director | Profile | |
| Douglas Ingram | Director | Profile | |
| Sharad Mansukani | Director | Profile | |
| Nancy Hutson | Independent Director | Profile | |
| Todd Sisitsky | Director | Profile | |
| Shane Cooke | Independent Director | Profile | |
| Jill Smith | Director | Profile | |
| Nina Goworek | Senior Director, Investor Relations | Profile | |
| Craig Paterson | Chief Medical Officer | Profile |
Endo International Workforce Analysis
Traditionally, organizations such as Endo International use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Endo International within its industry.Endo International Manpower Efficiency
Return on Endo International Manpower
| Revenue Per Employee | 944.2K | |
| Revenue Per Executive | 104.6M | |
| Net Loss Per Employee | 219.6K | |
| Net Loss Per Executive | 24.3M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Endo International PLC information on this page should be used as a complementary analysis to other Endo International's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Endo Stock
If you are still planning to invest in Endo International PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Endo International's history and understand the potential risks before investing.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |